CRISPR therapies targeting the next breakthrough in oncology
pharmaphorum
APRIL 20, 2022
As is typical, the research built on work going back years prior, specifically to 1987 when the first CRISPR mechanism was identified in E. coli, and their research in turn formed the foundation for the CRISPR-based therapies being explored to create new treatment options. Why cancer? The pipeline.
Let's personalize your content